Antiherpetic Medications May Reduce Risk for Dementia
Patients with herpes simplex virus infections may have a 2.56-fold increased risk for developing dementia, and using antiherpetic medications may decrease dementia risk.
Patients with herpes simplex virus infections may have a 2.56-fold increased risk for developing dementia, and using antiherpetic medications may decrease dementia risk.
CDC publishes the latest estimates of HSV-1, HSV-2 prevalence in the United States.
Young infants assessed for central nervous system infection rarely have herpes simplex virus.
A systematic review analyzed whether infection with HSV-2 increases risk of HIV acquisition.
An increased risk of herpes zoster was found in women, elderly patients, and patients with psoriasis.
A randomized trial shows that a candidate HSV-2 vaccine had a favorable safety profile and led to reduced shedding and lesion rates in human participants.
The new trivalent vaccine targets 3 different parts of the virus, shutting down its ability to enter cells and to evade detection by the immune system.
USPSTF recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults.
Frequent groomers of pubic hair are 3 to 4 times more likely to contract a STIs.
Researchers found that the 3-dose regimen was as effective as treatment with daily pills.